Feed Insights Top Reports Pricing

⌘K

16:13:38·1182d

SECFilingvia Quantisnow

SEC Form 10-K filed by Velo3D Inc.

ByQuantisnow·Wall Street's wire, on your screen.

VLD· Velo3D Inc.

Technology

Plus alert sent

Quantisnow Plus members were alerted at 16:13:40 ET - 2.0s after publication.

Sign up for Plus

Free Quantisnow account

Get notified the moment VLD files

Real-time alerts on SEC filings, FDA approvals, analyst ratings, insider trades, and press releases. Follow any ticker. No credit card.

Sign up free Log in

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VLD (Velo3D Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

CEO Kreger Bradley Allen converted options into 898 shares and sold $163 worth of shares (363 units at $0.45), increasing direct ownership by 6% to 9,341 units (SEC Form 4)
Velo3D Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Director Smith Ellen was granted 1,423 shares, increasing direct ownership by 8% to 18,440 units (SEC Form 4)
Director Bass Carl was granted 1,423 shares, increasing direct ownership by 6% to 24,146 units (SEC Form 4)
Director Toledano Gabrielle B was granted 1,423 shares, increasing direct ownership by 14% to 11,775 units (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022